Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (741-750 of 910) with videos related to

Pageof 91
Sort By:
Brain : a Journal of Neurology|March 5, 2003
Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical courseFerdinando Squitieri, Cinzia Gellera, Milena Cannella, et al.
Plos Pathogens|August 13, 2013
The Salmonella type III effector SspH2 specifically exploits the NLR co-chaperone activity of SGT1 to subvert immunityAmit P Bhavsar, Nat F Brown, Jan Stoepel, et al.
The Journal of Biological Chemistry|September 29, 2000
Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domainA S Hackam, A S Yassa, R Singaraja, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 11, 2000
Wild-type huntingtin protects from apoptosis upstream of caspase-3D Rigamonti, J H Bauer, C De-Fraja, et al.
Journal of Psychopathology and Clinical Science|April 10, 2025
Using behavioral economics to understand reinforcement mechanisms of loss-of-control eating: An ecological momentary assessment approachEmily K Burr, Lidia Z Meshesha, Robert D Dvorak, et al.
Journal of Huntington'S Disease|January 22, 2026
Silencing of human <i>HTT</i> by targeted CRISPR/dCas9-mediated epigenetic editingYi Lin Tay, Sarah B Thomson, Silvia Hnatova, et al.
Neurobiology of Disease|December 13, 2023
Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington diseaseStefan Bartl, Yuanyun Xie, Nalini Potluri, et al.
Journal of the American Pharmacists Association : Japha|February 3, 2024
Evaluation of pharmacist-led transition of care program in patients with acute coronary syndromeJove Graham, Stephen J Voyce, Jessica R Hayden, et al.
Journal of Lipid Research|December 23, 2009
Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemiaGunilla Olivecrona, Ewa Ehrenborg, Henrik Semb, et al.
Aging and Disease|May 18, 2023
Huntingtin Decreases Susceptibility to a Spontaneous Seizure Disorder in FVN/B MiceJeremy M Van Raamsdonk, Hilal H Al-Shekaili, Laura Wagner, et al.
Pageof 91

Showing results (741-750 of 910) with videos related to

Sort By:
Pageof 91
Brain : a Journal of Neurology|March 5, 2003
Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical courseFerdinando Squitieri, Cinzia Gellera, Milena Cannella, et al.
Plos Pathogens|August 13, 2013
The Salmonella type III effector SspH2 specifically exploits the NLR co-chaperone activity of SGT1 to subvert immunityAmit P Bhavsar, Nat F Brown, Jan Stoepel, et al.
The Journal of Biological Chemistry|September 29, 2000
Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domainA S Hackam, A S Yassa, R Singaraja, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 11, 2000
Wild-type huntingtin protects from apoptosis upstream of caspase-3D Rigamonti, J H Bauer, C De-Fraja, et al.
Journal of Psychopathology and Clinical Science|April 10, 2025
Using behavioral economics to understand reinforcement mechanisms of loss-of-control eating: An ecological momentary assessment approachEmily K Burr, Lidia Z Meshesha, Robert D Dvorak, et al.
Journal of Huntington'S Disease|January 22, 2026
Silencing of human <i>HTT</i> by targeted CRISPR/dCas9-mediated epigenetic editingYi Lin Tay, Sarah B Thomson, Silvia Hnatova, et al.
Neurobiology of Disease|December 13, 2023
Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington diseaseStefan Bartl, Yuanyun Xie, Nalini Potluri, et al.
Journal of the American Pharmacists Association : Japha|February 3, 2024
Evaluation of pharmacist-led transition of care program in patients with acute coronary syndromeJove Graham, Stephen J Voyce, Jessica R Hayden, et al.
Journal of Lipid Research|December 23, 2009
Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemiaGunilla Olivecrona, Ewa Ehrenborg, Henrik Semb, et al.
Aging and Disease|May 18, 2023
Huntingtin Decreases Susceptibility to a Spontaneous Seizure Disorder in FVN/B MiceJeremy M Van Raamsdonk, Hilal H Al-Shekaili, Laura Wagner, et al.
Pageof 91